Literature DB >> 3007578

von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.

L De Marco, A Girolami, T S Zimmerman, Z M Ruggeri.   

Abstract

We have studied three afibrinogenemic patients, who had only trace amounts of plasma and platelet fibrinogen as measured by radioimmunoassay, and demonstrate here that the residual aggregation observed in their platelet-rich plasma is dependent upon von Willebrand factor (vWF) binding to the platelet membrane glycoprotein (GP)IIb/IIIa complex. The abnormality of aggregation was more pronounced when ADP, rather than thrombin, collagen, or the combination of ADP plus adrenaline was used to stimulate platelets. With all stimuli, nevertheless, the platelet response was completely inhibited by a monoclonal antibody (LJP5) that is known to block vWF, but not fibrinogen binding to GPIIb/IIIa. Addition of purified vWF to the afibrinogenemic plasma resulted in marked increase in the rate and extent of aggregation, particularly when platelets were stimulated with ADP. This response was also completely blocked by LJP5. Addition of fibrinogen, however, restored normal aggregation even in the presence of LJP5, a finding consistent with the knowledge that antibody LJP5 has no effect on platelet aggregation mediated by fibrinogen binding to GPIIb/IIIa. Two patients gave their informed consent to receiving infusion of 1-desamino-8-D-arginine vasopressin (DDAVP), a vasopressin analogue known to raise the vWF levels in plasma by two- to fourfold. The bleeding time, measured before and 45 min after infusion, shortened from greater than 24 min to 12 min and 50 s in one patient and from 16 min to 9 min and 30 s in the other. Concurrently, the rate and extent of ADP-induced platelet aggregation improved after DDAVP infusion. The pattern, however, reversed to baseline levels within 4 h. The concentration of plasma vWF increased after DDAVP infusion, but that of fibrinogen remained at trace levels. We conclude that vWF interaction with GPIIb/IIIa mediates platelet-platelet interaction and may play a role in primary hemostasis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007578      PMCID: PMC424474          DOI: 10.1172/JCI112430

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Specific roles for platelet surface glycoproteins in platelet function.

Authors:  A T Nurden; J P Caen
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

2.  [CONSIDERATIONS ON PROLONGATION OF BLEEDING TIME IN CONGENITAL AFIBRINOGENEMIA].

Authors:  J CAEN; S INCEMAN
Journal:  Nouv Rev Fr Hematol       Date:  1963 Sep-Oct

3.  An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia.

Authors:  A T Nurden; J P Caen
Journal:  Br J Haematol       Date:  1974-10       Impact factor: 6.998

4.  Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis.

Authors:  H J Weiss; T B Tschopp; H R Baumgartner; I I Sussman; M M Johnson; J J Egan
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

5.  A report of a case of congenital afibrinogenemia.

Authors:  A Girolami; R Venturelli; G Bareggi
Journal:  Blut       Date:  1972-01

6.  Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia.

Authors:  H J Weiss; J Rogers
Journal:  N Engl J Med       Date:  1971-08-12       Impact factor: 91.245

7.  Congenital afibrinogenemia. A case report with some considerations on the hereditary transmission of this disorder.

Authors:  A Girolami; G Zacchelo; R D'Elia
Journal:  Thromb Diath Haemorrh       Date:  1971-06-30

8.  Platelet function in congenital afibrinogenemia.

Authors:  E Gugler; E F Lüscher
Journal:  Thromb Diath Haemorrh       Date:  1965-11-15

9.  Platelet adhesiveness and aggregation in congenital afibrinogenemia. An investigation of three patients with post-transfusion, cross-correction studies between two of them.

Authors:  A Girolami; L De Marco; L Virgolini; R Peruffo; F Fabris
Journal:  Blut       Date:  1975-02

10.  Platelet retention in glass bead columns: adhesion to glass and subsequent platelet-platelet interactions.

Authors:  J McPherson; M B Zucker
Journal:  Blood       Date:  1976-01       Impact factor: 22.113

View more
  31 in total

1.  Old concepts and new developments in the study of platelet aggregation.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.

Authors:  Miroslaw Rybaltowski; Yuko Suzuki; Hideo Mogami; Iwona Chlebinska; Tomasz Brzoska; Aki Tanaka; Fumiaki Banno; Toshiyuki Miyata; Tetsumei Urano
Journal:  Pflugers Arch       Date:  2011-04-15       Impact factor: 3.657

4.  Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.

Authors: 
Journal:  P T       Date:  2010-01

5.  Increased factor VIII/vWf levels in patients with reduced platelet number.

Authors:  A Casonato; F Fabris; M Boscaro; A Girolami
Journal:  Blut       Date:  1987-05

Review 6.  Thrombosis in Inherited Fibrinogen Disorders.

Authors:  Wolfgang Korte; Man-Chiu Poon; Alfonso Iorio; Michael Makris
Journal:  Transfus Med Hemother       Date:  2017-03-14       Impact factor: 3.747

7.  Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.

Authors:  H J Weiss; J Hawiger; Z M Ruggeri; V T Turitto; P Thiagarajan; T Hoffmann
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 8.  Platelet membrane glycoproteins and their function: an overview.

Authors:  T J Kunicki
Journal:  Blut       Date:  1989-07

9.  EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA.

Authors:  A Casonato; A Bertomoro; E Pontara; D Dannhauser; A R Lazzaro; A Girolami
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

Review 10.  Treatment of congenital fibrinogen deficiency: overview and recent findings.

Authors:  Konstantinos Tziomalos; Sofia Vakalopoulou; Vassilios Perifanis; Vassilia Garipidou
Journal:  Vasc Health Risk Manag       Date:  2009-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.